Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transient receptor potential melastatin channel TRPMPZQ (TRPMPZQ) is a parasite-specific, non-selective cation channel belonging to the transient receptor potential melastatin (TRPM) subfamily. It serves as the primary molecular target for the anthelmintic drug praziquantel (PZQ), which is widely used to treat schistosomiasis and other parasitic flatworm infections. TRPMPZQ is expressed in the muscle, nervous tissues, and sensory structures of parasitic flatworms like Schistosoma mansoni. Upon activation by praziquantel, the channel mediates a rapid and sustained influx of extracellular calcium (Ca2+) and sodium (Na+) ions, leading to membrane depolarization, spastic muscle paralysis, and severe damage to the parasite's tegument, ultimately resulting in worm death. Variations in the TRPMPZQ gene sequence or expression levels are directly linked to differences in drug sensitivity across different flatworm species and life cycle stages. For instance, the insensitivity of Fasciola hepatica (liver fluke) to praziquantel is attributed to a single amino acid difference in the TRPMPZQ binding pocket. Additionally, down-regulation or specific single nucleotide polymorphisms (SNPs) in TRPMPZQ have been associated with laboratory-selected praziquantel resistance, making the channel a critical focus for monitoring drug resistance and developing next-generation anthelmintics.
Agonism (channel activation leading to calcium influx)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential melastatin channel TRPMPZQ (TRPMPZQ).